Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Early Pulmonary Edema and Atrial Fibrillation Detection Using Implantable Devices

Technology #z05107

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Collections
Categories
Researchers
Robert Patterson, Professor Emeritus, Department of Physical Medicine and Rehabilitation
Dr. Patterson’s research interests include medical instrumentation and devices, bioelectricity, electrical stimulation and bioelectrical impedance.
External Link (www.pmr.umn.edu)
Andres Belalcazar
Senior Research Associate, University of Minnesota Medical School
Managed By
Jim Woodman
Technology Marketing Manager 612-626-3429
Patent Protection

US Patent pending

US Patent Pending 20070203420

Chronic Heart Disease Management

With an aging population, cost-effective management of chronic heart disease is a high priority. In particular, pacemaker and defibrillator companies are increasingly interested in adding sensors and monitors to implantable devices to monitor for signs of cardiac problems. With early warning, the cardiac patient can seek medical attention prior to a life threatening event, resulting in increased survival and reduced health care costs.

MN-IP Try and Buy
MN-IP Try and Buy deal terms are in the process of being posted. Contact Jim Woodman for specific details.

Early Pulmonary Edema and Atrial Fibrillation Detection

Inter-atrial block is a condition in which activation of the left atrium lags significantly behind the activation of the right atrium. Pulmonary edema creates pressure that can cause the left atrium to activate late in the cardiac cycle. Continuous monitoring of inter-atrial block using standard implantable leads on current pacemakers or defibrillators could be used for early pulmonary edema or atrial fibrillation detection. This method only requires slight changes to current pacemaker or defibrillator software and hardware.

BENEFITS OF MONITORING INTER-ATRIAL BLOCK AND PULMONARY EDEMA

  • Continuous monitoring ensures early warning of impending cardiac problems.
  • Monitoring both left and right atria increases sensitivity for early diagnosis of inter-atrial block, atrial fibrillation, pulmonary edema and heart disease.
  • Design requires minimal hardware and software changes to current implantable devices, saving cost in regulatory approval and manufacturing.
  • Flexible sizing for implantation as a pacemaker or a defibrillator allows incorporating across product lines.
  • Early detection of atrial fibrillation and pulmonary allows the patient to seek medical attention prior to a life threatening event.